What is Gefitinib?

Category: Prescription Drugs

Most popular types: Iressa


Gefitinib is an orally administered product that may be used for the treatment for locally advanced or metastatic non-small cell lung cancer that has failed prior therapy and that is positive for mutations of the epidermal growth factor receptor (EGFR).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 1
Moderate 4
Mild 3
None 3

Commonly reported side effects and conditions associated with Gefitinib

Side effect Patients
Diarrhea 5
Angina pain 1
Fatigue 1
Hair loss 1
Nail fungus 1
Nausea 1

Show all 9 reported side effects


Based on patients currently taking Gefitinib

Dosage Patients
250 mg every other day 1
250 mg daily 1

Why patients stopped taking Gefitinib

Multiple reasons could be selected

Reason Patients
Did not seem to work 4
Doctor's advice 1
Side effects too severe 1
See all 6 patients who've stopped taking Gefitinib


Currently taking Gefitinib

Duration Patients
1 - 2 years 2

Stopped taking Gefitinib

Duration Patients
1 - 6 months 4
6 months - 1 year 2
Adherence Evaluations
Always 10
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 10
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 1
$50-99 0
$25-49 0
< $25 5
Not specified 3

What people switch to and from

Patients started taking Gefitinib after stopping:

Treatment Patients
Erlotinib (Tarceva) 2
Chemotherapy 1
Pemetrexed (Alimta) 1

Patients stopped taking Gefitinib and switched to:

Treatment Patients
Osimertinib (Tagrisso) 2
Afatinib (Gilotrif) 1
Chemotherapy 1
Last updated:
There are no evaluations for Gefitinib.